Key result
Higher WHO functional class linked to ~2.9-fold higher mortality in fibrosing mediastinitis.
Why the study?
The etiology of fibrosing mediastinitis remains unclear, and long-term survival data and prognostic factors are poorly defined.
Cohort (n=369)
Yes
Answers are grounded in this paper and cite their sources.
Fibrosing mediastinitis carries a high prevalence of pulmonary hypertension (85.0%) and suboptimal 3-year survival (86.0%), with right heart failure markers (WHO functional class and lower-limb edema), diagnostic delay, and tuberculosis history predicting worse long-term mortality.
ibrosing mediastinitis (FM) is a rare disorder characterized by excessive fibrous tissue proliferation replacing normal mediastinal fat, leading to compression or invasion of critical mediastinal structures including pulmonary veins, pulmonary arteries and bronchi.1,2 These pathological changes may result in pulmonary hypertension (PH), right heart failure, and death.The etiology of FM remains unclear.Although tuberculosis (TB) has been proposed as a trigger in China, 3,4 robust evidence is lacking, and long-term survival data and prognostic factors remain poorly defined.We conducted a multicenter retrospective cohort study (ChiCTR2000037899) including 369 FM patients from 16 referral centers in 10 provinces in China between May 2010 and September 2021.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) conducted a cohort in Fibrosing mediastinitis (FM) (n=369). Fibrosing mediastinitis prognostic factors (e.g., WHO-FC, lower-limb edema, male sex, tuberculosis history) was evaluated on All-cause mortality (HR 2.91). Fibrosing mediastinitis had 1-, 2-, and 3-year survival rates of 93.1%, 88.7%, and 86.0%, with higher WHO functional class and lower-limb edema strongly predicting mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: